ClinicalTrials.gg
Drug

Napabucasin clinical trials

Also written BBI608 and BB608.

studies test it
19
open now
0
in phase 3
5
first study started
2009

How each study uses napabucasin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Napabucasin
14

Development codes

BBI608
18
BB608
10

Studies by the year they started

19 studies that test it; most in 2015 (7)

Studies that test napabucasin, by start year
YearStudies
20091
20111
20131
20142
20157
20164
20171
20182

By phase

A phase 1/2 study counts in both.

Phase 1
13
Phase 2
6
Phase 3
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 16 · Other 3

Sumitomo Pharma America, Inc. (13) · Sumitomo Pharma Co., Ltd. (3) · NCIC Clinical Trials Group (1) · Australasian Gastro-Intestinal Trials Group (1) · Takayuki Yoshino (1)

Often tested with

Tested in the same studies.

Amcasertib (2) · BNC 105 (1)

Studies

Open first, then newest update. How each study uses napabucasin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 19

Given beside what is tested · 5 — napabucasin is usual care or a partner of the new treatment

Codes

What other systems call napabucasin · ClinicalTrials.gg INT000728

  • UNII (FDA) Z1HHM49K7ONAPABUCASINConfirmed FDA, Wikidata
  • Wikidata Q27294876napabucasinConfirmed FDA, Wikidata
  • NCI Thesaurus C96429NapabucasinOne source FDA
  • DrugBank DB12155One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.